Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 24,000 shares at $29.38 ($705K) on 2017-07-07, disclosed to the SEC on 2017-07-07.
Open-market sale of $705k JUNO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.38 | 23,600 | $693K | 98.3% |
| 2 | $30.00 | 400 | $12K | 1.7% |
| Total | $29.39 avg | 24,000 | $705K | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |